Personalized medicine in rheumatoid arthritis: miles to go before we sleep.
作者信息
Plenge Robert M, Bridges S Louis
出版信息
Arthritis Rheum. 2011 Mar;63(3):590-3. doi: 10.1002/art.30126.
Abstract
摘要
相似文献
1
Personalized medicine in rheumatoid arthritis: miles to go before we sleep.类风湿关节炎的个性化医疗：路漫漫其修远兮。
Arthritis Rheum. 2011 Mar;63(3):590-3. doi: 10.1002/art.30126.
2
Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci.类风湿关节炎中抗肿瘤坏死因子治疗疗效的遗传预测因子的全基因组关联研究确定了与七个基因座多态性的关联。
Arthritis Rheum. 2011 Mar;63(3):645-53. doi: 10.1002/art.30130.
3
Moving towards personalized medicine in rheumatoid arthritis.迈向类风湿关节炎的个性化医疗
Arthritis Res Ther. 2014;16(3):110. doi: 10.1186/ar4565.
4
Pharmacogenetics: Anti-TNF therapy in RA--towards personalized medicine?药物遗传学：类风湿关节炎的抗 TNF 治疗——迈向个体化医疗？
Nat Rev Rheumatol. 2011 Mar;7(3):136-8. doi: 10.1038/nrrheum.2011.13. Epub 2011 Feb 8.
5
TNF antagonists opened the way to personalized medicine in rheumatoid arthritis.肿瘤坏死因子拮抗剂为类风湿关节炎的个性化医疗开辟了道路。
Mol Med. 2014 Dec 16;20 Suppl 1(Suppl 1):S7-9. doi: 10.2119/molmed.2014.00168.
6
Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis.类风湿关节炎患者抗 TNF 药物反应的全基因组关联分析。
Ann Rheum Dis. 2013 Aug;72(8):1375-81. doi: 10.1136/annrheumdis-2012-202405. Epub 2012 Dec 11.
7
A longitudinal genome-wide association study of anti-tumor necrosis factor response among Japanese patients with rheumatoid arthritis.一项针对日本类风湿性关节炎患者抗肿瘤坏死因子反应的全基因组纵向关联研究。
Arthritis Res Ther. 2016 Jan 18;18:12. doi: 10.1186/s13075-016-0920-6.
8
A personalized medicine approach to biologic treatment of rheumatoid arthritis: a preliminary treatment algorithm.类风湿关节炎生物治疗的个体化医学方法：初步治疗算法。
Rheumatology (Oxford). 2012 Apr;51(4):600-9. doi: 10.1093/rheumatology/ker300. Epub 2011 Sep 2.
9
The need for personalised medicine for rheumatoid arthritis.类风湿关节炎的个体化医学需求。
Ann Rheum Dis. 2011 Jan;70(1):4-7. doi: 10.1136/ard.2010.135376. Epub 2010 Nov 10.
10
Novel approaches to discovery of biomarkers in rheumatoid arthritis: comment on the article by Oswald et al.类风湿关节炎生物标志物发现的新方法：对奥斯瓦尔德等人文章的评论
Arthritis Rheumatol. 2015 May;67(8):2276-7. doi: 10.1002/art.39189.
引用本文的文献
1
Decision Impact Analysis to Measure the Influence of Molecular Signature Response Classifier Testing on Treatment Selection in Rheumatoid Arthritis.决策影响分析：评估分子特征反应分类器检测对类风湿关节炎治疗选择的影响
Rheumatol Ther. 2024 Feb;11(1):61-77. doi: 10.1007/s40744-023-00618-1. Epub 2023 Nov 10.
2
Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts.GWAS 鉴定的抗 TNF 药物反应变异在类风湿关节炎中的验证：两个大型队列的荟萃分析。
Front Immunol. 2021 Oct 27;12:672255. doi: 10.3389/fimmu.2021.672255. eCollection 2021.
3
Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis.类风湿关节炎中肿瘤坏死因子抑制剂治疗反应的全基因组关联研究。
Pharmacogenomics J. 2018 Sep;18(5):657-664. doi: 10.1038/s41397-018-0040-6. Epub 2018 Aug 31.
4
Markers of treatment response to methotrexate in rheumatoid arthritis: where do we stand?类风湿关节炎中对甲氨蝶呤治疗反应的标志物：我们目前的状况如何？
Int J Rheumatol. 2012;2012:978396. doi: 10.1155/2012/978396. Epub 2012 Jul 9.
本文引用的文献
1
Hundreds of variants clustered in genomic loci and biological pathways affect human height.数以百计的变异体聚集在基因组位置和生物途径中，影响人类身高。
Nature. 2010 Oct 14;467(7317):832-8. doi: 10.1038/nature09410. Epub 2010 Sep 29.
2
A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury.一项全基因组研究鉴定出与罗美昔布相关肝损伤相关的 HLA 等位基因。
Nat Genet. 2010 Aug;42(8):711-4. doi: 10.1038/ng.632. Epub 2010 Jul 18.
3
Genome-wide association studies in pharmacogenomics: successes and lessons.药物基因组学中的全基因组关联研究：成功与教训。
Pharmacogenet Genomics. 2013 Aug;23(8):383-94. doi: 10.1097/FPC.0b013e32833d7b45.
4
Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.吉非替尼或化疗用于治疗具有突变型 EGFR 的非小细胞肺癌。
N Engl J Med. 2010 Jun 24;362(25):2380-8. doi: 10.1056/NEJMoa0909530.
5
The path to personalized medicine.个性化医疗之路。
N Engl J Med. 2010 Jul 22;363(4):301-4. doi: 10.1056/NEJMp1006304. Epub 2010 Jun 15.
6
Integration of genetic, clinical, and INR data to refine warfarin dosing.整合基因、临床和 INR 数据以优化华法林剂量。
Clin Pharmacol Ther. 2010 May;87(5):572-8. doi: 10.1038/clpt.2010.13. Epub 2010 Apr 7.
7
Integrating pathway analysis and genetics of gene expression for genome-wide association studies.整合通路分析和基因表达的遗传学用于全基因组关联研究。
Am J Hum Genet. 2010 Apr 9;86(4):581-91. doi: 10.1016/j.ajhg.2010.02.020. Epub 2010 Mar 25.
8
Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy.类风湿性关节炎风险等位基因PTPRC也与抗肿瘤坏死因子α治疗的反应相关。
Arthritis Rheum. 2010 Jul;62(7):1849-61. doi: 10.1002/art.27457.
9
Electronic medical records for discovery research in rheumatoid arthritis.电子病历在类风湿关节炎研究中的应用。
Arthritis Care Res (Hoboken). 2010 Aug;62(8):1120-7. doi: 10.1002/acr.20184.
10
Associations between tumor necrosis factor-alpha (TNF-alpha) -308 and -238 G/A polymorphisms and shared epitope status and responsiveness to TNF-alpha blockers in rheumatoid arthritis: a metaanalysis update.肿瘤坏死因子-α（TNF-α）-308 和 -238 G/A 多态性与共享表位状态及对 TNF-α 阻滞剂反应性在类风湿关节炎中的关系：荟萃分析更新。
J Rheumatol. 2010 Apr;37(4):740-6. doi: 10.3899/jrheum.090707. Epub 2010 Mar 1.
Zotero 插件